相當於500多萬人民幣
Adaptimmune is launching Tecelra — a one-time treatment — at a list price of $727,000, the most expensive per-dose cost of any cellular medicine for cancer in the U.S.
一批準國內就報道了:
https://mp.weixin.qq.com/s/MKieLSCwtzcWk5XoVG_E3g
更多我的博客文章>>>